上海醫藥(02607.HK)旗下瑞舒伐他汀鈣片獲菲律賓藥品註冊證書
上海醫藥(02607.HK)公布,旗下瑞舒伐他汀鈣片收到菲律賓食品藥品監督管理局頒發的藥品註冊證書,該藥品獲得批准上市。
瑞舒伐他汀鈣片主要用於治療經飲食控制和其它非藥物治療仍不能適當控制血脂異常的原發性高膽固醇血症或混合型血脂異常症;也適用於純合子家族性高膽固醇血症的患者,作為飲食控制和其它降脂措施
的輔助治療,或在這些方法不適用時使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.